Köck, R.; Denkel, L.; Feßler, A.T.; Eicker, R.; Mellmann, A.; Schwarz, S.; Geffers, C.; Hübner, N.-O.; Leistner, R.
Clinical Evidence for the Use of Octenidine Dihydrochloride to Prevent Healthcare-Associated Infections and Decrease Staphylococcus aureus Carriage or Transmission—A Review. Pathogens 2023, 12, 612.
https://doi.org/10.3390/pathogens12040612
AMA Style
Köck R, Denkel L, Feßler AT, Eicker R, Mellmann A, Schwarz S, Geffers C, Hübner N-O, Leistner R.
Clinical Evidence for the Use of Octenidine Dihydrochloride to Prevent Healthcare-Associated Infections and Decrease Staphylococcus aureus Carriage or Transmission—A Review. Pathogens. 2023; 12(4):612.
https://doi.org/10.3390/pathogens12040612
Chicago/Turabian Style
Köck, Robin, Luisa Denkel, Andrea T. Feßler, Rudolf Eicker, Alexander Mellmann, Stefan Schwarz, Christine Geffers, Nils-Olaf Hübner, and Rasmus Leistner.
2023. "Clinical Evidence for the Use of Octenidine Dihydrochloride to Prevent Healthcare-Associated Infections and Decrease Staphylococcus aureus Carriage or Transmission—A Review" Pathogens 12, no. 4: 612.
https://doi.org/10.3390/pathogens12040612
APA Style
Köck, R., Denkel, L., Feßler, A. T., Eicker, R., Mellmann, A., Schwarz, S., Geffers, C., Hübner, N.-O., & Leistner, R.
(2023). Clinical Evidence for the Use of Octenidine Dihydrochloride to Prevent Healthcare-Associated Infections and Decrease Staphylococcus aureus Carriage or Transmission—A Review. Pathogens, 12(4), 612.
https://doi.org/10.3390/pathogens12040612
